Who Paid My Doc
Perclose Proglide
Device Vascular
PDI 08717648013089
General payments
$426,406
Research payments
$517,354
Through program year 2024, $426,406 in general payments and $517,354 in research payments were reported against Perclose Proglide (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $257,025 | 1,180 |
| 2023 | General | $48,055 | 895 |
| 2022 | General | $121,325 | 2,787 |
| 2022 | Research | $349,811 | 77 |
| 2021 | Research | $167,543 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
4,862 general · 85 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.